section name header

Indications ⬇

REMS


Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

CV: peripheral edema, palpitations

Derm: flushing

GI: abdominal pain, nausea

Neuro: dizziness, drowsiness, fatigue

Interactions ⬆ ⬇

Drug-drug:

Availability ⬆ ⬇

Route/Dosage ⬆ ⬇

Hepatic Impairment

US Brand Names ⬆ ⬇

Conjupri

Action ⬆ ⬇

  • Inhibits the transport of calcium into myocardial and vascular smooth muscle cells, resulting primarily in peripheral arterial vasodilation.
Therapeutic effects:
  • Reduction in blood pressure.

Classifications ⬆ ⬇

Therapeutic Classification: antihypertensives

Pharmacologic Classification: calcium channel blockers

Pharmacokinetics ⬆ ⬇

Absorption: Well absorbed after oral administration (64–90%).

Distribution: Unknown.

Protein Binding: 93%.

Metabolism/Excretion: Mostly metabolized by the liver; primarily excreted in urine (10% as unchanged drug).

Half-Life: 30–50 hr.

Time/Action Profile ⬆ ⬇

(plasma concentrations)

ROUTEONSETPEAKDURATION
POunknown6–12 hrunknown

Patient/Family Teaching ⬆ ⬇

Pronunciation ⬆

lev-am-LOE-di-peen